FFIV insider sale: 1,300 shares via Morgan Stanley; recent August/September disposals

Rhea-AI Filing Summary

Form 144 notice reports a proposed sale of 1,300 common shares by Francois Locoh-Donou through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $416,793.00. The issuer’s outstanding shares are listed as 57,447,170. The shares to be sold were originally acquired as restricted stock: 252 shares on 05/01/2021 and 1,048 shares on 02/01/2021. The filing also discloses two recent sales by the same person in the past three months: 1,300 shares on 09/02/2025 for $402,493.00 and 1,300 shares on 08/01/2025 for $400,582.00. The notice includes the required certification that the seller is not aware of undisclosed material adverse information.

Positive

• Full Rule 144 disclosure provided including broker, quantities, acquisition dates, and recent sales, supporting regulatory compliance.

Negative

• Insider selling activity (multiple recent disposals) could be interpreted as liquidity-taking by an executive, though amounts are small relative to outstanding shares.

Insights

Financial Analyst

TL;DR: Insider sale is small relative to share count and appears procedural under Rule 144; minimal direct financial impact.

The proposed sale of 1,300 shares represents approximately 0.0023% of the reported 57,447,170 shares outstanding, indicating immaterial dilution or market impact. The shares were restricted grants from 2021 and are being sold through a brokerage, consistent with routine insider liquidity events. Two similar-sized sales were completed in August and September 2025, suggesting a pattern of small periodic dispositions rather than a single large exit.

Corporate Governance Expert

TL;DR: Filing meets Rule 144 disclosure requirements and includes standard insider certification; governance impact is limited.

The notice properly identifies the broker, class, quantities, acquisition dates, and nature of acquisition (restricted stock), satisfying typical Rule 144 reporting elements. The seller’s representation about lack of undisclosed material adverse information is included, and recent sales are disclosed, supporting transparency. From a governance perspective, the transactions appear compliant and routine; no adverse governance events are reported in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1300	416793.00	57447170	10/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2021	Restricted Stock	ISSUER			252	05/01/2021	Not Applicable
Common	02/01/2021	Restricted Stock	ISSUER			1048	02/01/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
FRANCOIS LOCOH-DONOU 801 5TH AVENUE Seattle WA 98104	Common	09/02/2025	1300	402493.00
FRANCOIS LOCOH-DONOU 801 5TH AVENUE Seattle WA 98104	Common	08/01/2025	1300	400582.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for F5 (FFIV) report?

It reports a proposed sale of 1,300 common shares by Francois Locoh-Donou through Morgan Stanley Smith Barney with an aggregate market value of $416,793.00.

How many shares outstanding does the filing list for the issuer?

The filing lists 57,447,170 shares outstanding for the issuer.

When were the shares being sold originally acquired?

The shares were acquired as restricted stock on 02/01/2021 (1,048 shares) and 05/01/2021 (252 shares).

Were there recent sales by the same person?

Yes. The filing discloses sales of 1,300 shares on 09/02/2025 (gross proceeds $402,493.00) and 1,300 shares on 08/01/2025 (gross proceeds $400,582.00).

Through which broker will the proposed sale occur?

The proposed sale is through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York, NY, as listed in the filing.

Does the filing state whether the seller knows of any undisclosed material information?

Yes. The notice includes the seller’s representation that they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.